Triple Vaccine Boostrix Approved For Senior Patients By US FDA
The FDA (US Food and Drug Administration) has approved the triple vaccine "Boostrix" - for tetanus, diphtheria and pertussis (whooping cough) - for individuals aged 65+ years. Boostrix is made by GlaxoSmithKline Biologicals. This is the first triple vaccine for older patients. Before Boostrix's approval, available multiple vaccines only protected against tetanus and diphtheria. Boostrix is given ...

Are Two FDA Approvals in One Week a Positive Sign?
Don't count on it.

Minnesota lawmakers critique FDA medical devices policy over IDEs
The medical device industry s favorite Congressional delegation has fired another salvo at the FDA approvals process. Minnesota s entire Congressional delegation sent a letter Thursday to U.S. Food and Drug Administration Commissioner Margaret Hamburg saying they are very concerned about the Investigational Device Exemption (IDE) review process. The delegation cites some of the industry s ...